Welcome to Hypothesize That!Hypothesize That!, is our new science podcast, where science meets conjecture and curiosity and the biggest ‘What If’s’ come to life. Hosted by health journalist Nicola Hill, each episode features leaders in their field who confront some of the most provocative trends, theories, and questions shaping the future of Pharma R&D.…And don’t miss Crimes Against Innovation, where questionable brilliance takes the stage and bad ideas go head-to-head in a battle of bold gone wrong, and only one will be pronounced guilty for the ultimate act of genius-turned-folly!We don’t stop there, though! The courtroom extends to you. Join the conversation on social media to cast your own verdicts – do you agree with our host’s ruling or have your own case to present?Share your thoughts on social media using #HypothesizeThat and #CrimesAgainstInnovation. Episode 3: Gene therapy’s future: will patient engagement eclipse science? Could the success of gene therapy depend as much – or more so – on patient engagement as on scientific breakthroughs? Host Nicola Hill welcomes Laurence Woollard, Patient Advocate and Founder of On The Pulse, and Dr Emma Lane, UCB’s Global Patient Engagement Lead, to explore how the evolving partnership between patients and the pharmaceutical industry could redefine the future of gene therapy. Listen to the insights of tomorrow – today. Episode 3 (BONUS): Crimes Against Innovation - Gender Bias in Trials vs. The Five-to-Ten-Year Promise False promises in drug development timelines. Gender inequalities in clinical trials. Both undeniable injustices – but which will host Nicola Hill deem the greatest crime against innovation? Join Laurence Woollard and Dr Emma Lane as they face off in this compelling discussion. Listen now! Episode 2: Within the next 10 years, will traditional clinical trials be obsolete? Could the rise of fully virtualized, decentralized clinical trials (DCTs) mean the end of clinical trials as we know them? Host Nicola Hill poses that very question to guests Craig Lipset, Co-Chair of the Decentralized Trials and Research Alliance, and Lewis Millen, UCB’s Global Clinical Sciences & Operations Innovation Lead. Listen to learn: is digital health technology our friend or foe? Episode 2 (BONUS): Crimes Against Innovation - Theranos Deception vs. Incrementalism’s Trap Scandal and deceit take the front seat in this bonus mini-episode. Lewis Millen argues that Theranos was a crime not only in the legal sense, while Craig Lipset ‘confesses’ his own crime against innovation. It is up to host Nicola Hill to decide which argument steals the spotlight. Think you can crack the case? Listen in and pick a side. Episode 1: The end of wet labs? How digital is virtualizing pharma research Introducing Hypothesize That! In the first episode of this new podcast, host Nicola Hill is joined by Professor Russ Altman from Stanford University, and Dr Alistair Henry, UCB’s Chief Scientific Officer, to explore how AI and digital tools are transforming drug discovery and pharmaceutical research. Could digital tools fully replace hands-on lab work, or is a hybrid approach the future of pharma research? Listen to find out… Episode 1 (BONUS): Crimes Against Innovation - The Milestone Myth vs. The Hunger for Innovation Think you know the biggest crime against innovation? In this bonus mini-episode, host Nicola Hill moderates a lively debate as Professor Russ Altman and Dr Alistair Henry give two very different answers. Are rigid milestones stifling scientific creativity, or is over-resourcing killing breakthroughs? Who is right? Listen now and join the debate.
